Generic Drug Substitution Revisited
- 4 June 1987
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 316 (23) , 1456-1462
- https://doi.org/10.1056/nejm198706043162306
Abstract
IN the past few decades, concern about reducing health care costs has led to attempts to increase the dispensing of generic drug products. First, physicians were encouraged to write prescriptions specifying a generic product.1 , 2 Second, state antisubstitution laws were modified to permit or even mandate generic substitution, even if the prescription did not include the generic name of the drug.3 Third, the Food and Drug Administration (FDA) published a list of drug products thought to be interchangeable.4 Finally, and perhaps most important, the Drug Price Competition and Patent Term Restoration Act was enacted in 1984.5 One of its chief goals . . .Keywords
This publication has 27 references indexed in Scilit:
- The Promise of PharmacoepidemiologyAnnual Review of Pharmacology and Toxicology, 1987
- Cost and price of comparable branded and generic pharmaceuticalsPublished by American Medical Association (AMA) ,1986
- Generic Equivalents: Issues and ConcernsThe Journal of Clinical Pharmacology, 1986
- A Time to Speak Out on Bioequivalence and Therapeutic EquivalenceThe Journal of Clinical Pharmacology, 1986
- Postmarketing studies of drug efficacyArchives of internal medicine (1960), 1985
- Assessment of 75/75 Rule: FDA ViewpointJournal of Pharmaceutical Sciences, 1983
- Mental Health and the Elderly: New Biopharmaceutic ConsiderationsHealth Affairs, 1983
- Can postmarketing surveillance help to effect optimal drug therapy?JAMA, 1979
- Bioavailability of 11 phenytoin productsJournal of Pharmacokinetics and Biopharmaceutics, 1977
- FORMULATION AND THERAPEUTIC EFFICACY OF DRUGS USED IN CLINICAL TRIALSThe Lancet, 1969